Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 7, 2005, Pages 1359-1363

  Devaraj, Sridevi ^a   Du Clos, Terry W ^b   Jialal, Ishwarlal ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Laboratory for Atherosclerosis and Metabolic Research   (United States)

Author keywords

Atherothrombosis; C reactive protein; Endothelial cells; Fcgamma receptors; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; VASCULAR CELL ADHESION MOLECULE 1;

AORTA; ARTICLE; ATHEROSCLEROSIS; BIOTINYLATION; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION;

ANTIBODIES; AORTA; ATHEROSCLEROSIS; BIOTINYLATION; C-REACTIVE PROTEIN; CELLS, CULTURED; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LEUKOCYTES; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, IGG; VASCULAR CELL ADHESION MOLECULE-1;

EID: 21544476183     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000168573.10844.ae     Document Type: Article

References (30)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
2. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl Y, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation. 2003;107:499-511.
4. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004;44:6-11.
5. Verma S, Yen ET. C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1253-R1256.
6. Venugopal SK, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens. 2005;14:33-37.
7. Salmon JE, Pricop L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum. 2001;44:739-750.
8. Tebo JM, Mortensen RF. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. J Immunol. 1990;144:231-238.
9. Zahedi K, Tebo JM, Siripont J, Klimo GF, Mortensen RF. Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors. J Immunol 1989;142:2384-2392.
10. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med. 1999;190:585-590.
11. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW. C-reactive protein binds to Fcgamma RI in transfected COS cells. J Immunol 1995;155:2185-2193.
12. Favaloro EJ. Differential expression of surface antigens on activated endothelium. Immunol Cell Biol I993;71:571-581.
13. Groger M, Sarmay G, Fiebiger E, Wolff K, Petzelbauer P. Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. J Immunol. 1996;156:1549-1556.
14. Sedmak DD, Davis DH, Singh U, van de Winkel JG, Anderson CL. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. An immunohistochemical study. Am J Pathol. 1991;138: 175-181.
15. Groger M, Fischer GF, Wolff K, Petzelbauer P. Immune complexes from vasculitis patients bind to endothelial Fc receptors independent of the allelic polymorphism of FcgammaRIIa. J Invest Dermatol. 1999;113: 56-60.
16. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003;107:398-404.
17. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439-1441.
18. Devaraj S, Kumaresan PR, Jiaial I. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol. 2004;36:405-410.
19. Chi M, Tridandapani S, Zhong W, Coggeshall KM, Mortensen RF. C-reactive protein induces signaling through Fcgamma RIIa on HL-60 granulocytes. J Immunol. 2002;168:1413-1418.
20. Crowell RE, Du Clos TW, Montoya G, Heaphy E, Mold C. C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fcgamma RI. J Immunol. 1991;147:3445-3451.
21. Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C, Du Clos TW. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest. 2000;105: 369-376.
22. Bodman-Smith KB, Melendez AJ, Campbell I, Harrison PT, Allen JM, Raynes JG. C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI). Immunology. 2002;107:252-260.
23. Vielma S, Virella G, Gorod A, Lopes-Virella M. Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of Fcgamma receptor II (FcgammaRlI). Clin Immunol. 2002;104: 265-273.
24. Escribano-Burgos M, Lopez-Farre A, del Mar Gonzalez M, Macaya C, Garcia-Mendez A, Mateos-Caceres PJ, Alonso-Orgaz S, Carrasco C, Rico LA, Porres Cubero JC. Effect of C-reactive protein on Fcgamma receptor II in cultured bovine endothelial cells. Clin Sci (Lond). 2005;108:85-91.
25. Pan LF, Kreisle RA, Shi YD. Detection of Fcgamma receptors on human endothelial cells stimulated with cytokines tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). Clin Exp Immunol. 1998;112:533-538.
26. Woollard KJ, Phillips DC, Griffiths HR. Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol. 2002;130:256-262.
27. Williams TN, Zhang CX, Game BA, He L, Huang Y. C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arterioscler Thromb Vasc Biol. 2004;24:61-66.
28. Han KH, Hong KH, Park JH, Ko J, Kang DH, Choi KJ, Hong MK, Park SW, Park SJ. C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation. 2004;109: 2566-2571.
29. Li L, Roumeliotis N, Sawamura T, Renier G. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res. 2004;95: 877-883.
30. Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003;108: 1676-1678.